GlassScriptPhysician profile
James W Ferguson
NPI 1730183013
$2,332.14
in general payments reported to CMS, 2019-2025
12 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $601 · 2021: $364 · 2022: $222 · 2023: $147 · 2024: $342 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $349.77 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $348.33 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $332.69 | 2021-2025 | Farxiga |
| Lilly USA, LLC | $283.47 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $243.11 | 2020 | |
| Allergan, INC. | $194.90 | 2019-2020 | |
| Pfizer INC. | $130.37 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $120.11 | 2019 | |
| Amarin Pharma, INC. | $111.74 | 2020 | |
| Abbvie INC. | $111.60 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.53 | 2019 | |
| Alydia Health | $7.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.